Patients' perception of implantable cardioverter defibrillator deactivation at the end of life

被引:27
作者
Hill, Loreena [1 ,2 ]
McIlfatrick, Sonja [1 ,3 ]
Taylor, Brian [1 ]
Dixon, Lana [2 ]
Harbinson, Mark [2 ]
Fitzsimons, Donna [1 ,2 ,3 ]
机构
[1] Univ Ulster, Inst Nursing Res, Newtownabbey BT37 0QB, North Ireland
[2] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[3] All Ireland Inst Hosp & Palliat Care, Dublin, Ireland
关键词
Review; systematic; defibrillators; implantable; terminal care; decision-making; EXPERT CONSENSUS STATEMENT; PATIENTS NEARING END; REQUESTING WITHDRAWAL; ELECTRONIC DEVICES; CARE; ICD; PERSPECTIVES; PREFERENCES; MANAGEMENT; ATTITUDES;
D O I
10.1177/0269216314550374
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Individualised care at the end of life requires professional understanding of the patient's perception of implantable cardioverter defibrillator deactivation. Aim: The aim was to evaluate the evidence on patients' perception of implantable cardioverter defibrillator deactivation at end of life. Design: Systematic narrative review of empirical studies was published during 2008-2014. Data Sources: Data were collected from six databases, citations from relevant articles and expert recommendations. Results: In all, 18 studies included with collective population of n=5810. Concept mapping highlighted three themes: (1) Diverse preferences regarding discussion and deactivation. Deactivation was rarely discussed pre-implantation, with some studies demonstrating patients' reluctance to discuss implantable cardioverter defibrillator deactivation at any stage. Two studies found the majority of patients valued such discussions. Diversity was reflected in patients' willingness to deactivate, ranging from 12% (n=9) in Irish cohort to 79% (n=195) in Dutch study. (2) Ethical and legal considerations were predominant in Canadian and American literature as patients wanted to contribute but felt the decision should be a doctor's responsibility. Advance directives were uncommon in Europe, and where they existed the implantable cardioverter defibrillator was not mentioned. (3) Living in the now' was evident as despite deteriorating symptoms many patients maintained a positive outlook and anticipated surviving more than 10years. Several studies asserted living longer was more important than quality of life. Conclusion: Patients regard the implantable cardioverter defibrillator as a complex and solely beneficial device, with little insight regarding its potential impact on a peaceful death. This review confirms the need for professionals to discuss with patients and families implantable cardioverter defibrillator functionality and deactivation at appropriate opportunities.
引用
收藏
页码:310 / 323
页数:14
相关论文
共 61 条
[1]   Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure [J].
Allen, Larry A. ;
Yager, Jonathan E. ;
Funk, Michele Jonsson ;
Levy, Wayne C. ;
Tulsky, James A. ;
Bowers, Margaret T. ;
Dodson, Gwen C. ;
O'Connor, Christopher M. ;
Felker, G. Michael .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (21) :2533-2542
[2]  
[Anonymous], 10 QUEST HELP YOU MA
[3]  
[Anonymous], BRIT HEART FDN HEART
[4]  
[Anonymous], ROL BRIT HEART FDN H
[5]  
[Anonymous], PACE
[6]  
[Anonymous], SYST REV CRD GUID UN
[7]  
[Anonymous], IMPL CARD DEF ARRH R
[8]  
[Anonymous], 1982, MEASURING SOCIAL JUD
[9]  
[Anonymous], Journal of the American College of Cardiology, DOI DOI 10.1016/J.JACC.2008.02.033
[10]  
Ballentine Jennifer M, 2005, Am J Hosp Palliat Care, V22, P14, DOI 10.1177/104990910502200106